Literature DB >> 12531552

GD3 ganglioside and apoptosis.

Florence Malisan1, Roberto Testi.   

Abstract

Lipid and glycolipid mediators are important messengers of the adaptive responses to stress, including apoptosis. In mammalian cells, the intracellular accumulation of ganglioside GD3, an acidic glycosphingolipid, contributes to mitochondrial damage, a crucial event during the apoptopic program. GD3 is a minor ganglioside in most normal tissues. Its expression increases during development and in pathological conditions such as cancer and neurodegenerative disorders. Intriguingly, GD3 can mediate additional biological events such as cell proliferation and differentiation. These diverse and opposing effects indicate that tightly regulated mechanisms, including 9-O-acetylation, control GD3 function, by affecting intracellular levels, localization and structure of GD3, and eventually dictate biological outcomes and cell fate decisions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12531552     DOI: 10.1016/s1388-1981(02)00339-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  37 in total

Review 1.  Sialidase significance for cancer progression.

Authors:  Taeko Miyagi; Kohta Takahashi; Keiko Hata; Kazuhiro Shiozaki; Kazunori Yamaguchi
Journal:  Glycoconj J       Date:  2012-05-29       Impact factor: 2.916

2.  Sialidase NEU3 is a peripheral membrane protein localized on the cell surface and in endosomal structures.

Authors:  Gabriele Zanchetti; Paolo Colombi; Marta Manzoni; Luigi Anastasia; Luigi Caimi; Giuseppe Borsani; Bruno Venerando; Guido Tettamanti; Augusto Preti; Eugenio Monti; Roberto Bresciani
Journal:  Biochem J       Date:  2007-12-01       Impact factor: 3.857

Review 3.  Multi-system disorders of glycosphingolipid and ganglioside metabolism.

Authors:  You-Hai Xu; Sonya Barnes; Ying Sun; Gregory A Grabowski
Journal:  J Lipid Res       Date:  2010-03-08       Impact factor: 5.922

4.  A General Chemoenzymatic Strategy for the Synthesis of Glycosphingolipids.

Authors:  Yunpeng Liu; Liuqing Wen; Lei Li; Madhusudhan Reddy Gadi; Wanyi Guan; Kenneth Huang; Zhongying Xiao; Mohui Wei; Cheng Ma; Qing Zhang; Hai Yu; Xi Chen; Peng George Wang; Junqiang Fang
Journal:  European J Org Chem       Date:  2016-08-16

5.  Cytotoxicity of liposomal alpha-tocopheryl succinate towards hamster cheek pouch carcinoma (HCPC-1) cells in culture.

Authors:  Xinbin Gu; Joel L Schwartz; Xiaowu Pang; Yanfei Zhou; David A Sirois; Rajagopalan Sridhar
Journal:  Cancer Lett       Date:  2005-11-03       Impact factor: 8.679

6.  Involvement of 9-O-Acetyl GD3 ganglioside in Mycobacterium leprae infection of Schwann cells.

Authors:  Victor Túlio Ribeiro-Resende; Michelle Lopes Ribeiro-Guimarães; Robertha Mariana Rodrigues Lemes; Isis Cristina Nascimento; Lucinéia Alves; Rosalia Mendez-Otero; Maria Cristina Vidal Pessolani; Flávio Alves Lara
Journal:  J Biol Chem       Date:  2010-08-25       Impact factor: 5.157

7.  Disialogangliosides and TNFα alter gene expression for cytokines and chemokines in primary brain cell cultures.

Authors:  Donna M Byers; John C Gorbet; Louis N Irwin
Journal:  Neurochem Res       Date:  2011-10-01       Impact factor: 3.996

8.  Targeting the GD3 acetylation pathway selectively induces apoptosis in glioblastoma.

Authors:  Suzanne M Birks; John Owusu Danquah; Linda King; Reinhardt Vlasak; Dariusz C Gorecki; Geoffrey J Pilkington
Journal:  Neuro Oncol       Date:  2011-07-31       Impact factor: 12.300

9.  A new approach to comparing anti-CD20 antibodies: importance of the lipid rafts in their lytic efficiency.

Authors:  Mariam Hammadi; Jacques-Olivier Pers; Christian Berthou; Pierre Youinou; Anne Bordron
Journal:  Onco Targets Ther       Date:  2010-06-24       Impact factor: 4.147

10.  GD3 accumulation in cell surface lipid rafts prior to mitochondrial targeting contributes to amyloid-β-induced apoptosis.

Authors:  Jong-Kook Kim; Sang-Ho Kim; Hee-Young Cho; Hee-Soo Shin; Hye-Ryen Sung; Jin-Ran Jung; Mei-Lian Quan; Dong-Hong Jiang; Hae-Rahn Bae
Journal:  J Korean Med Sci       Date:  2010-09-17       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.